| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6145734 | American Journal of Obstetrics and Gynecology | 2014 | 49 Pages |
Abstract
In the first such report, we demonstrated the feasibility of the use of metabolomic developing biomarkers for the first-trimester prediction of CHD. Abnormal lipid metabolism appeared to be a significant feature of CHD pregnancies.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Ray O. MD, MBA, Rebecca MD, Rupasri PhD, Trent C. PhD, Argyro Syngelaki, Beomsoo PhD, Edison BSc, Philip B. BSc, Zeynep Alpay-Savasan, David S. PhD, Kypros H. MD,